During the past decade, University of Minnesota Masonic Cancer Center conducted 232 clinical trials. In the 10-year time frame, 232 clinical trials started and 179 clinical trials were completed, i.e. on average, 77.2% percent of trials that started reached the finish line to date. In the past 5 years, 89 clinical trials started and 95 clinical trials were completed. i.e. 106.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Minnesota Masonic Cancer Center" #1 sponsor was "Masonic Cancer Center, University of Minnesota" with 190 trials, followed by "Children's Oncology Group" with 119 trials sponsored, "National Cancer Institute (NCI)" with 101 trials sponsored, "Alliance for Clinical Trials in Oncology" with 63 trials sponsored and "Gynecologic Oncology Group" with 63 trials sponsored. Other sponsors include 171 different institutions and companies that sponsored additional 93 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Minnesota Masonic Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 300 trials as a collaborator, "Cancer and Leukemia Group B" with 25 trials as a collaborator, "Eastern Cooperative Oncology Group" with 17 trials as a collaborator, "SWOG Cancer Research Network" with 17 trials as a collaborator and "Children's Oncology Group" with 11 trials as a collaborator. Other collaborators include 145 different institutions and companies that were collaborators in the rest 97 trials.

According to Clinical.Site data, the most researched conditions in "University of Minnesota Masonic Cancer Center" are "Leukemia" (59 trials), "Lymphoma" (50 trials), "Ovarian Cancer" (39 trials), "Breast Cancer" (31 trials) and "Recurrent Malignant Solid Neoplasm" (29 trials). Many other conditions were trialed in "University of Minnesota Masonic Cancer Center" in a lesser frequency.

Most popular intervention types in "University of Minnesota Masonic Cancer Center" are "Drug" (529 trials), "Biological" (213 trials), "Other" (199 trials), "Procedure" (174 trials) and "Radiation" (128 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (108 trials), "Cyclophosphamide" (77 trials), "cyclophosphamide" (58 trials), "filgrastim" (44 trials) and "Questionnaire Administration" (43 trials). Other intervention names were less common.

The vast majority of trials in "University of Minnesota Masonic Cancer Center" are 569 trials for "All" genders, 111 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are 204 active trials in "University of Minnesota Masonic Cancer Center". 3 are not yet recruiting, 88 are recruiting, 111 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 366 completed trials in University of Minnesota Masonic Cancer Center, 5 suspended trials, and 97 terminated clinical trials to date.

Out of the total trials that were conducted in University of Minnesota Masonic Cancer Center, 143 "Phase 1" clinical trials were conducted, 331 "Phase 2" clinical trials and 165 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 49 trials that are defined as “Not Applicable".